+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Cholesterol Testing Market By Indication (Atherosclerosis, Diabetes, Obesity, Others), By Product (Test Strips, Test Kits), By End-Product, By Test, By Age, By Region, Forecast & Opportunities, 2025

  • PDF Icon

    Report

  • May 2020
  • Region: Global
  • TechSci Research
  • ID: 5022682
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Cholesterol Testing Market is expected to grow at brisk rate during the forecast period owing reasons like surge in risk of cardiovascular diseases & obesity, surge in aging population and rising awareness and adoption of preventive healthcare. Additionally, increase in healthcare expenditure by various governments around the world is also driving the cholesterol testing market. Furthermore, rapid technological advancements in cholesterol testing and growing focus on developing new products are the key factors contributing to the constant growth of technological advancements in cholesterol testing market globally.

A complete cholesterol test is also called a lipid panel or lipid profile. The test can be used to measure the amount of “good” and “bad” cholesterol and triglycerides, a type of fat, in a person’s blood. Too much LDL cholesterol in blood may put the person at risk for heart disease and other serious conditions. High LDL levels can cause the build-up of plaque, a fatty substance that narrows the arteries and blocks blood from flowing normally. Additionally, growing health concerns among the population is creating huge demand for cholesterol testing. Moreover, government is also trying to improve the quality of testing and thus, the cholesterol testing market is anticipated to hold a huge growth potential for the market players in the coming years.

The Global Cholesterol Testing Market is segmented based indication, product, end-product, test, age, end-user and region. Based on end-user, the market is segmented between hospitals & clinics, homecare and others. In 2019, hospitals & clinics segment held the largest market share owing to increasing number of patients performed in hospitals and rising number of hospitals and clinics around the world with advanced laboratory infrastructure.

Major players operating in the Global Cholesterol Testing Market include Abaxis, Inc., Abbott Laboratories, Akers Biosciences, Inc., Beckman Coulter, Inc., Bio-Reference Laboratories, Boston Heart Diagnostics Corporation, Cell Biolabs, Inc, Clinical Reference Laboratory, Inc., F. Hoffmann-La Roche Ltd, Prima Lab SA, PTS Diagnostics, Quest Diagnostics, Randox Laboratories, Sekisui Diagnostics, LLC, Siemens Healthineers, Sigma-Aldrich Corporation, Spectra Laboratories, SpectraCell Laboratories, Inc, Thermo Fisher Scientific, Unilabs and others. The market players are focusing on various strategic initiatives like regional expansion, new product development and strategic collaborations and partnerships.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and forecast the market size of the Global Cholesterol Testing Market.
  • To classify and forecast the Global Cholesterol Testing Market based on indication, product, end-product, test, age, end-user, company and regional distribution.
  • To identify drivers and challenges for the Global Cholesterol Testing Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Cholesterol Testing Market.
  • To conduct pricing analysis for the Global Cholesterol Testing Market.
  • To identify and analyze the profile of leading players operating in the Global Cholesterol Testing Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of companies across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the companies which could not be identified due to the limitations of secondary research. The author analyzed the presence of all major players across the globe.

The author calculated the market size of the Global Cholesterol Testing Market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Cholesterol testing companies, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to cholesterol testing
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as companies, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Cholesterol Testing Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Indication:
  • Atherosclerosis
  • Diabetes
  • Obesity
  • Others

Market, By Product:
  • Test Strips
  • Test Kits
  • Without meter
  • With meter
  • Mail-in

Market, By End-Product:
  • Total cholesterol
  • High-density lipoprotein (HDL) cholesterol
  • Low-density lipoprotein (LDL) cholesterol
  • Triglycerides

Market, By Test:
  • Lipid Panel Test/Complete Lipid Profile
  • Apolipoprotein B Test
  • Apolipoprotein A-1 Test
  • Apoe Genotyping Test
  • Apolipoprotein CII
  • Others

Market, By Age:
  • Before Puberty
  • Puberty
  • Adulthood

Market, By End-User:
  • Hospitals & Clinics
  • Homecare
  • Others

Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape:
Company Profiles: Detailed analysis of the major companies present in the Global Cholesterol Testing Market.

Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.

Table of Contents

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Cholesterol Testing Market4. Executive Summary5. Voice of Customer
6. Global Cholesterol Testing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Atherosclerosis, Diabetes, Obesity, Others)
6.2.2. By Product (Test Strips, Test Kits (Without meter, With meter, Mail-in))
6.2.3. By End-Product (Total cholesterol, High-density lipoprotein (HDL) cholesterol, Low-density lipoprotein (LDL) cholesterol, Triglycerides)
6.2.4. By Test (Lipid Panel Test/Complete Lipid Profile, Apolipoprotein B Test, Apolipoprotein A-1 Test, Apoe Genotyping Test, Apolipoprotein CII, Others)
6.2.5. By Age (Before Puberty, Puberty, Adulthood)
6.2.6. By End-User (Hospitals & Clinics, Homecare, Others)
6.2.7. By Company (2019)
6.2.8. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Cholesterol Testing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Product
7.2.3. By End-Product
7.2.4. By Type
7.2.5. By Age
7.2.6. By End-User
7.2.7. By Country
7.3. Market Attractiveness Index
7.4. Asia-Pacific: Country Analysis
7.4.1. China Cholesterol Testing Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Indication
7.4.1.2.2. By Product
7.4.1.2.3. By End-Product
7.4.1.2.4. By Type
7.4.1.2.5. By Age
7.4.1.2.6. By End-User
7.4.2. India Cholesterol Testing Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Indication
7.4.2.2.2. By Product
7.4.2.2.3. By End-Product
7.4.2.2.4. By Type
7.4.2.2.5. By Age
7.4.2.2.6. By End-User
7.4.3. Japan Cholesterol Testing Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Indication
7.4.3.2.2. By Product
7.4.3.2.3. By End-Product
7.4.3.2.4. By Type
7.4.3.2.5. By Age
7.4.3.2.6. By End-User
7.4.4. South Korea Cholesterol Testing Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Indication
7.4.4.2.2. By Product
7.4.4.2.3. By End-Product
7.4.4.2.4. By Type
7.4.4.2.5. By Age
7.4.4.2.6. By End-User
7.4.5. Singapore Cholesterol Testing Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Indication
7.4.5.2.2. By Product
7.4.5.2.3. By End-Product
7.4.5.2.4. By Type
7.4.5.2.5. By Age
7.4.5.2.6. By End-User
7.4.6. Australia Cholesterol Testing Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Indication
7.4.6.2.2. By Product
7.4.6.2.3. By End-Product
7.4.6.2.4. By Type
7.4.6.2.5. By Age
7.4.6.2.6. By End-User
8. Europe Cholesterol Testing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Product
8.2.3. By End-Product
8.2.4. By Type
8.2.5. By Age
8.2.6. By End-User
8.2.7. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. France Cholesterol Testing Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Indication
8.4.1.2.2. By Product
8.4.1.2.3. By End-Product
8.4.1.2.4. By Type
8.4.1.2.5. By Age
8.4.1.2.6. By End-User
8.4.2. Germany Cholesterol Testing Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Indication
8.4.2.2.2. By Product
8.4.2.2.3. By End-Product
8.4.2.2.4. By Type
8.4.2.2.5. By Age
8.4.2.2.6. By End-User
8.4.3. United Kingdom Cholesterol Testing Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Indication
8.4.3.2.2. By Product
8.4.3.2.3. By End-Product
8.4.3.2.4. By Type
8.4.3.2.5. By Age
8.4.3.2.6. By End-User
8.4.4. Italy Cholesterol Testing Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Indication
8.4.4.2.2. By Product
8.4.4.2.3. By End-Product
8.4.4.2.4. By Type
8.4.4.2.5. By Age
8.4.4.2.6. By End-User
8.4.5. Russia Cholesterol Testing Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Indication
8.4.5.2.2. By Product
8.4.5.2.3. By End-Product
8.4.5.2.4. By Type
8.4.5.2.5. By Age
8.4.5.2.6. By End-User
8.4.6. Spain Cholesterol Testing Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Indication
8.4.6.2.2. By Product
8.4.6.2.3. By End-Product
8.4.6.2.4. By Type
8.4.6.2.5. By Age
8.4.6.2.6. By End-User
9. North America Cholesterol Testing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Product
9.2.3. By End-Product
9.2.4. By Type
9.2.5. By Age
9.2.6. By End-User
9.2.7. By Country
9.3. Market Attractiveness Index
9.4. North America: Country Analysis
9.4.1. United States Cholesterol Testing Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Indication
9.4.1.2.2. By Product
9.4.1.2.3. By End-Product
9.4.1.2.4. By Type
9.4.1.2.5. By Age
9.4.1.2.6. By End-User
9.4.2. Mexico Cholesterol Testing Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Indication
9.4.2.2.2. By Product
9.4.2.2.3. By End-Product
9.4.2.2.4. By Type
9.4.2.2.5. By Age
9.4.2.2.6. By End-User
9.4.3. Canada Cholesterol Testing Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Indication
9.4.3.2.2. By Product
9.4.3.2.3. By End-Product
9.4.3.2.4. By Type
9.4.3.2.5. By Age
9.4.3.2.6. By End-User
10. South America Cholesterol Testing Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Product
10.2.3. By End-Product
10.2.4. By Type
10.2.5. By Age
10.2.6. By End-User
10.2.7. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Cholesterol Testing Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Indication
10.4.1.2.2. By Product
10.4.1.2.3. By End-Product
10.4.1.2.4. By Type
10.4.1.2.5. By Age
10.4.1.2.6. By End-User
10.4.2. Argentina Cholesterol Testing Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Indication
10.4.2.2.2. By Product
10.4.2.2.3. By End-Product
10.4.2.2.4. By Type
10.4.2.2.5. By Age
10.4.2.2.6. By End-User
10.4.3. Colombia Cholesterol Testing Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Indication
10.4.3.2.2. By Product
10.4.3.2.3. By End-Product
10.4.3.2.4. By Type
10.4.3.2.5. By Age
10.4.3.2.6. By End-User
11. Middle East and Africa Cholesterol Testing Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Product
11.2.3. By End-Product
11.2.4. By Type
11.2.5. By Age
11.2.6. By End-User
11.2.7. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. South Africa Cholesterol Testing Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Indication
11.4.1.2.2. By Product
11.4.1.2.3. By End-Product
11.4.1.2.4. By Type
11.4.1.2.5. By Age
11.4.1.2.6. By End-User
11.4.2. Saudi Arabia Cholesterol Testing Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Indication
11.4.2.2.2. By Product
11.4.2.2.3. By End-Product
11.4.2.2.4. By Type
11.4.2.2.5. By Age
11.4.2.2.6. By End-User
11.4.3. UAE Cholesterol Testing Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Indication
11.4.3.2.2. By Product
11.4.3.2.3. By End-Product
11.4.3.2.4. By Type
11.4.3.2.5. By Age
11.4.3.2.6. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Abaxis, Inc.
14.2.2. Abbott Laboratories
14.2.3. Akers Biosciences, Inc.
14.2.4. Beckman Coulter, Inc.
14.2.5. Bio-Reference Laboratories
14.2.6. Boston Heart Diagnostics Corporation
14.2.7. Cell Biolabs, Inc
14.2.8. Clinical Reference Laboratory, Inc.
14.2.9. F. Hoffmann-La Roche Ltd
14.2.10. Prima Lab SA
14.2.11. PTS Diagnostics
14.2.12. Quest Diagnostics
14.2.13. Randox Laboratories
14.2.14. Sekisui Diagnostics, LLC
14.2.15. Siemens Healthineers
14.2.16. Sigma-Aldrich Corporation
14.2.17. Spectra Laboratories
14.2.18. SpectraCell Laboratories, Inc
14.2.19. Thermo Fisher Scientific
14.2.20. Unilabs
15. Strategic Recommendations16. About Us & Disclaimer

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abaxis, Inc.
  • Abbott Laboratories
  • Akers Biosciences, Inc.
  • Beckman Coulter, Inc.
  • Bio-Reference Laboratories
  • Boston Heart Diagnostics Corporation
  • Cell Biolabs, Inc
  • Clinical Reference Laboratory, Inc.
  • F. Hoffmann-La Roche Ltd
  • Prima Lab SA
  • PTS Diagnostics
  • Quest Diagnostics
  • Randox Laboratories
  • Sekisui Diagnostics, LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corporation
  • Spectra Laboratories
  • SpectraCell Laboratories, Inc
  • Thermo Fisher Scientific
  • Unilabs